An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Rationale, Development, and Design

Click to increase image sizeClick to decrease image size

Acknowledgments

This project was funded by the Bristol Myers Squibb Foundation. The authors are grateful for the contributions of the Advisory Committee and the Technical Expert Panel in the development and beta testing of the OCCM. The Advisory Committee included Christopher S. Lathan, MD, MS, MPH, and Randall A. Oyer, MD, as co-chairs and the following members: Thomas M. Asfeldt, MBA, RN, BAN; John V. Cox, DO, MBA, FACP, FASCO; Becky DeKay, MBA; Andrea Ferris, MBA; Lovell Jones, PhD; Matthew J. Loscalzo, LCSW; James Mulshine, MD; Kathleen Nolan, MPH; Shawn M. Regis, PhD; Maureen Rigney, LICSW; Cardinale B. Smith, MD, PhD; and Mark S. Soberman, MD, MBA, FACS. The Technical Expert Panel included Thomas M. Asfeldt, MBA, RN, BAN, as chair and the following members: Karyl Blaseg, MSN, RN, OCN; Richard Deming, MD; and Nancy Johnson, MSM.

The authors thank patients and participating staff at the development and beta testing sites across the United States for their contributions to the OCCM. The five Development Sites were AdventHealth Daytona Beach (formerly Florida Hospital Memorial Medical Center), Florida; Genesis HealthCare System, Genesis Cancer Care Center, Ohio; MaineGeneral Health, Maine; Mary Bird Perkins — Our Lady of the Lake Cancer Center, Louisiana; and Sidney Kimmel Cancer Center at Thomas Jefferson University, Pennsylvania. The seven Beta Testing Sites were AdventHealth Daytona Beach (formerly Florida Hospital Memorial Medical Center), Florida; Advocate Lutheran General Hospital, Lutheran General Cancer Institute, Illinois; Ascension Wheaton Memorial Medical Center, Wisconsin; Genesis HealthCare System, Genesis Cancer Care Center, Ohio; Cowell Family Cancer Center, Munson Healthcare, Michigan; Northwest Medical Specialties, Washington; and Southern Ohio Medical Center, Ohio.

Medical writing support was provided by Melissa Furtado, MPH, of Cactus Life Sciences (part of Cactus Communications) and funded by the Bristol Myers Squibb Foundation. The authors retained full control of the content of this editorial and approved the final version for submission.